Crescendo: ANGLE inks contract with Crescendo for use of CTC biomarkers in clinical trials
ANGLE plc, one of the world─leading liquid biopsy companies, is delighted to announce that it has signed a contract with a new customer, Crescendo Biologics Limited (Crescendo). Crescendo is a UK─based,
Read full article »
Crescendo is an England-based clinical-stage immuno-oncology company that researches and develops T-cell human body therapeutics for the treatment of cancer.
Read more